Oxford University and Evotec’s drug discovery partnership launched last year to quickly accelerate drugs to market begins making awards.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Oxford spinout Celleron Therapeutics raises funding from South Korean consortium of investors for small molecule treatments.
OxSonics, an Oxford University spinout established in 2013 to develop ultrasound therapeutics, has secured £9.4m in series B equity financing, bringing its total external fundraising to £14.2m.
Oxford University Innovation launches 24 companies in 2016 with a combined £52.6m in early stage funding, setting a new record in spinout generation for the UK and Europe.
Oxford Sciences Innovation's latest fundraising rounds off year which saw Oxford University Innovation launch 22 new spinout companies.
Atopix Therapeutics Limited, a UK biotechnology company with roots back to Oxford University, has been acquired by Italian pharmaceutical firm Chiesi Farmaceutici Spa.
Oxford University, Oxford University Innovation, Oxford Sciences Innovation and Evotec announce a new partnership to advance the development of next-generation medicines arising from Oxford research.